Article
Characterization of cancer-related somatic mutations in the adenosine A2B receptor.
European journal of pharmacology - 5 Aug 2020
Wang Xuesong, Jespers Willem, Bongers Brandon J, Habben Jansen Maria C C, Stangenberger Chantal M, Dilweg Majlen A, Gutiérrez-de-Terán Hugo, IJzerman Adriaan P, Heitman Laura H, van Westen Gerard J P
Abstract excerpt
In cancer, G protein-coupled receptors (GPCRs) are involved in tumor progression and metastasis. In this study we particularly examined one GPCR, the adenosine A2B receptor. This receptor is activated by high concentrations of its endogenous ligand adenosine, which suppresses the immune response to fight tumor progression. A series of adenosine A2B receptor mutations were retrieved from the Cancer Genome Atlas...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
